"En plaçant depuis toujours l’innovation et l’excellence au cœur de sa stratégie, la clinique ovo s’assure de pouvoir répondre à vos attentes et soutenir votre projet parental."

During the past decade, Clinique OVO conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique OVO" #1 sponsor was "Clinique Ovo" with 18 trials, followed by "Bayer" with 4 trials sponsored, "Beckman Coulter, Inc." with 1 trials sponsored, "Dr François Bissonnette" with 1 trials sponsored and "Ferring Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique OVO" #1 collaborator was "Ferring Pharmaceuticals" with 4 trials as a collaborator, "Clinique Ovo" with 1 trials as a collaborator, "Create Fertility Center" with 1 trials as a collaborator, "EMD Serono" with 1 trials as a collaborator and "Genevrier Laboratories" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Clinique OVO" are "Infertility" (11 trials), "Endometriosis" (2 trials), "Abortion, Spontaneous" (1 trials), "Anti-Mullerian Hormone" (1 trials) and "Embryo Implantation" (1 trials). Many other conditions were trialed in "Clinique OVO" in a lesser frequency.

Most popular intervention types in "Clinique OVO" are "Drug" (13 trials), "Other" (4 trials), "Procedure" (4 trials), "Diagnostic Test" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Vilaprisan (BAY1002670)" (2 trials), "Access AMH Assay" (1 trials), "AdhesioRT" (1 trials) and "Adjuvant Growth Hormon" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique OVO" are 26 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique OVO". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Clinique OVO, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique OVO, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".